Description
Mitrofan 50mg/1000mg Tablets contain a combination of Sitagliptin and Metformin, used in the management of type 2 diabetes mellitus. This combination helps improve glycemic control through complementary mechanisms, including enhancing insulin response and reducing glucose production.
Manufactured by Amros Pharmaceuticals under strict pharmaceutical quality standards, Mitrofan ensures safety, consistency, and reliable therapeutic performance. The product is available in a fixed-dose combination tablet for convenient administration.
Dosage & Administration:
Dosage depends on patient condition and response to treatment. It is taken orally as prescribed by a qualified healthcare professional, usually with meals.
Possible Side Effects:
May include nausea, diarrhea, abdominal discomfort, or headache. In some cases, hypoglycemia or gastrointestinal disturbances may occur. Serious side effects are rare but require medical attention.
Use only under the supervision of a licensed medical practitioner.
